Cystitis: from urothelial cell biology to clinical applications

Biomed Res Int. 2014:2014:473536. doi: 10.1155/2014/473536. Epub 2014 Apr 30.

Abstract

Cystitis is a urinary bladder disease with many causes and symptoms. The severity of cystitis ranges from mild lower abdominal discomfort to life-threatening haemorrhagic cystitis. The course of disease is often chronic or recurrent. Although cystitis represents huge economical and medical burden throughout the world and in many cases treatments are ineffective, the mechanisms of its origin and development as well as measures for effective treatment are still poorly understood. However, many studies have demonstrated that urothelial dysfunction plays a crucial role. In the present review we first discuss fundamental issues of urothelial cell biology, which is the core for comprehension of cystitis. Then we focus on many forms of cystitis, its current treatments, and advances in its research. Additionally we review haemorrhagic cystitis with one of the leading causative agents being chemotherapeutic drug cyclophosphamide and summarise its management strategies. At the end we describe an excellent and widely used animal model of cyclophosphamide induced cystitis, which gives researches the opportunity to get a better insight into the mechanisms involved and possibility to develop new therapy approaches.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents, Alkylating / therapeutic use
  • Cyclophosphamide / therapeutic use
  • Cystitis* / drug therapy
  • Cystitis* / metabolism
  • Cystitis* / pathology
  • Cystitis* / physiopathology
  • Hemorrhage / drug therapy
  • Hemorrhage / metabolism
  • Hemorrhage / pathology
  • Hemorrhage / physiopathology
  • Humans
  • Urothelium* / metabolism
  • Urothelium* / pathology
  • Urothelium* / physiopathology

Substances

  • Antineoplastic Agents, Alkylating
  • Cyclophosphamide